Art
J-GLOBAL ID:202002266421931755   Reference number:20A2545648

α-type-1 polarized dendritic cell-based vaccination in newly diagnosed high-grade glioma: A phase II clinical trial

悪性グリオーマに対する活性化樹状細胞ワクチンを用いたがん免疫療法-第2相試験
Author (7):
Material:
Volume: 79th  Page: ROMBUNNO.PJ12-2-7 (WEB ONLY)  Publication year: 2020 
JST Material Number: U0661A  Document type: Proceedings
Article type: 会議録記事  Country of issue: Japan (JPN)  Language: ENGLISH (EN)
Thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
Semi thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=20A2545648&from=J-GLOBAL&jstjournalNo=U0661A") }}
JST classification (3):
JST classification
Category name(code) classified by JST.
Immunotherapy for tumors  ,  Tumors(=neoplasms)of nervous system  ,  Clinical application of immunotherapeutic agents and blood preparations 
Terms in the title (5):
Terms in the title
Keywords automatically extracted from the title.

Return to Previous Page